Know Cancer

or
forgot password

Personalized Decision Aid for the Management of Gastroesophageal Reflux Disease


N/A
18 Years
N/A
Not Enrolling
Both
Gastroesophageal Reflux Disease, Esophageal Cancer, Barrett's Esophagus

Thank you

Trial Information

Personalized Decision Aid for the Management of Gastroesophageal Reflux Disease


Inclusion Criteria:



- Patients with GERD,

- Age at least 18,

- Able to give consent

Exclusion Criteria:

- Unable to perform decision aid on a computer

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Participant acceptability

Outcome Description:

Patients will be surveyed after using the intervention to determine if they felt it was useful and whether they would recommend it to others.

Outcome Time Frame:

Patients will be surveyed on the day of the decision aid (1 day).

Safety Issue:

No

Authority:

United States: Institutional Review Board

Study ID:

2012-MGH-Hur-GERD

NCT ID:

NCT01641887

Start Date:

January 2014

Completion Date:

December 2016

Related Keywords:

  • Gastroesophageal Reflux Disease
  • Esophageal Cancer
  • Barrett's Esophagus
  • GERD
  • Heartburn
  • Decision Aid
  • Barrett Esophagus
  • Esophageal Diseases
  • Esophageal Neoplasms
  • Gastroesophageal Reflux

Name

Location

Massachusetts General Hospital Boston, Massachusetts  02114-2617